Latest stories on SPRO
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics COO Timothy Keutzer to retire
The Fly44 · neutralgeneral
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
StockTitan58 · neutralproduct/pr
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
GlobeNewswire58 · neutralproduct/pr
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
GlobeNewswire52 · neutralproduct/pr
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Business Insider52 · neutralproduct/pr
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
H.C. Wainwright raises Spero Therapeutics price target to $6
Investing.com Analyst Ratings61 · neutralanalyst
Spero Therapeutics price target raised to $6 from $5 at H.C. Wainwright
The Fly61 · neutralanalyst
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics files $300M mixed securities shelf
The Fly28 · bearishgeneral
Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
The Motley Fool55 · neutralearnings
Spero outlines cash runway into the second half of 2029 following $105M royalty financing
Seeking Alpha56 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Spero Therapeutics Q2 Earnings Call Highlights
Yahoo Finance67 · bullishearnings
Spero Therapeutics GAAP EPS of -$0.16
Seeking Alpha34 · bearishearnings
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
StockTitan42 · neutralearnings